Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the

S Kyun Lim1, F Michael Hoffmann

  • 1McArdle Laboratory for Cancer Research and Laboratory of Genetics, University of Wisconsin, Madison, WI 53706, USA.

Insights

Smad4 activates c-myc expression and cell growth independently of TGF-beta by binding to promoter elements. Inhibiting Smad4-LEF/TCF interaction reduces c-myc and cell proliferation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The c-myc protooncogene regulates cell proliferation.
  • Transforming growth factor-beta (TGF-beta) inhibits c-myc expression in epithelial cells.
  • Wnt ligands promote c-myc expression and cell proliferation.

Purpose of the Study:

  • To investigate the role of Smad4 in regulating c-myc expression.
  • To explore the interaction between Smad4 and Wnt signaling pathway components.
  • To determine the TGF-beta-independent functions of Smad4 in c-myc regulation.

Main Methods:

  • Peptide aptamer inhibition of Smad4-LEF/TCF binding.
  • RNA interference (RNAi) for Smad4 knockdown.
  • Analysis of c-myc promoter activity and gene expression.
  • Assessment of cell proliferation and cell death.

Main Results:

  • A peptide aptamer targeting Smad4-LEF/TCF interaction reduced c-myc expression and HepG2 cell growth.
  • Smad4 binds to the TBE1 element of the c-myc promoter, activating its activity independently of TGF-beta.
  • TGF-beta reduces Smad4 binding to TBE1, consistent with its inhibitory role.
  • Smad4 knockdown reduced c-myc levels and sensitized cells to serum deprivation-induced death.
  • Tumor-derived Smad4 mutants retained the ability to activate c-myc with LEF1.

Conclusions:

  • Smad4 possesses a novel TGF-beta-independent function in activating c-myc expression.
  • Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor (LEF/TCF) to promote c-myc expression and cell growth.
  • Targeting the Smad4-LEF/TCF interaction may offer therapeutic strategies for cancers driven by aberrant c-myc expression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...